New indication for AclastaNovartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. PENSIONS: Canadian pension rules outdated ORTHOPEDICS: That shoe may not fit Ontario looking at wider non-physician prescribing Will examine scopes of practice for allied health professionals EDITORIAL: What economic crisis means to the profession ORTHOPEDICS: Device allows movement while supporting spine Prescription recycling back in the limelight CMA leader-to-be admits to redistributing unused meds 10 questions with... Dr. Bill Anderson Medical politician urges MDs to get active in grassroots lobb LETTERS: Pathology hardly ailing in Ontario BAD ADVICE: Psychiatrists, don't shrink from sudoku First Previous 4013 4014 4015 4016 4017 Next Last
